Heart surgery hope: drug may raise low platelets before operation

NCT ID NCT07278661

Recruiting now Disease control Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study tests a drug called romiplostim to see if it can safely increase platelet counts in people with low platelets before they have heart surgery. Low platelets can make surgery risky, and this treatment aims to reduce the need for blood transfusions. About 136 adults scheduled for heart surgery will receive either romiplostim or a placebo before their operation, and doctors will monitor their platelet levels and any side effects closely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHIRURGICAL INTERVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

thrombocytopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHIRURGICAL INTERVENTION THROMBOCYTOPAENIA

Contacts and locations

Locations

CHU d'Angers
NOT_YET_RECRUITING

Angers, France
CHU de Bordeaux
NOT_YET_RECRUITING

Bordeaux, France
CHU de Brest
NOT_YET_RECRUITING

Brest, France
CHU de Dijon
NOT_YET_RECRUITING

Dijon, France
CHU de Nantes
RECRUITING

Nantes, France
CHU de Rennes
NOT_YET_RECRUITING

Rennes, France
CHU de Strasbourg
NOT_YET_RECRUITING

Strasbourg, France
Hôpital Bichat (AP-HP)
NOT_YET_RECRUITING

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.